Tests a support program for social needs in young adults with type 1 diabetes
Tests a navigator-based support program in adults aged 18 to 40 with type 1 diabetes.
Plain-language title generated from the registry record
Registry title: T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Key facts
- Where
- New Haven, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Source: NCT07059806, who can take part
Where in United States
- Yale Adult Diabetes CenterNew Haven, United StatesTaking people
- Yale Children's Diabetes CenterNew Haven, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yale University
- Trial code
- NCT07059806
- Record updated
- 26 October 2026
- Original description
Randomized controlled trial with a wait list control arm. Participants will be randomized 2:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.Read full original descriptionShow less
T1CARE: A Randomized Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Randomized controlled trial with a wait list control arm. Participants will be randomized 2:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.
Inclusion: Type 1 Diabetes; fluent in Spanish or English who reside in the greater New Haven area.
Exclusion: cognitive impairment and otherwise unable to give written informed consent about participating in this study.